GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition
UK pharmaceuticals giant GSK PLC said Tuesday that it plans to buy Aiolos Bio Inc. for $1.4 billion as it seeks to expand its respiratory pipeline.
( 1
min )